Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AzarGen Biotechnologies

AzarGen Biotechnologies
2003 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$3.1M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of human therapeutic proteins designed to increase the survivability of premature-born infants. The company's human therapeutic proteins are made using advanced plant-based genetic engineering and synthetic biology techniques and it also offers a plant based expression technology which comprises optimal combinations of novel synthetic promoters, combined with enhancer and purification components, enabling medical professionals to offers drugs with superior clinical efficacy at low cost that can significantly improve the health status of citizens.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Biotechnology
Primary Office
  • Natural Science Building, Room 2066
  • Merriman Avenue, Stellenbosch
  • Cape Town
  • South Africa

+27 021 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AzarGen Biotechnologies’s full profile, request a free trial.

AzarGen Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 07-Jan-2016 $3.1M 00.00 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AzarGen Biotechnologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Industrial Development Corporation of South Africa Corporate Development Minority 000 0000 000000 0
South African Government Government 000 0000 000000 0

AzarGen Biotechnologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Mauritz Venter Ph.D Co-Founder & Chief Executive Officer
Cobus Zwiegelaar Ph.D Co-Founder, Chief-Scientist & Chief Operating Officer